# BCKDHB

## Overview
The BCKDHB gene encodes the E1 beta subunit of the branched-chain alpha-keto acid dehydrogenase (BCKD) complex, a critical enzyme complex involved in the catabolism of branched-chain amino acids (BCAAs) such as leucine, isoleucine, and valine. This gene is essential for the proper functioning of the BCKD complex, which plays a pivotal role in energy production and nitrogen balance within cells by converting BCAAs into acyl-CoA derivatives for further metabolic processing (Du2022The; Zneimer1991Regional). The BCKD complex is a mitochondrial multienzyme structure, and the E1 beta subunit, encoded by BCKDHB, is a component of the E1 heterotetramer, which is responsible for the decarboxylation of branched-chain alpha-keto acids (Ævarsson2000Crystal). Mutations in the BCKDHB gene can lead to metabolic disorders such as maple syrup urine disease (MSUD), characterized by the accumulation of BCAAs and their corresponding keto acids due to impaired enzymatic activity (Flaschker2007Description; Wang2012Two).

## Structure
The BCKDHB gene encodes the E1 beta subunit of the branched-chain alpha-keto acid dehydrogenase complex, which is essential for the catabolism of branched-chain amino acids. The primary structure of the BCKDHB protein consists of a specific sequence of amino acids that determine its function and interactions. The secondary structure of the protein includes alpha helices and beta sheets, which contribute to its stability and folding. The tertiary structure involves the three-dimensional folding of the protein, allowing it to achieve its functional conformation. In terms of quaternary structure, the BCKDHB protein assembles with other subunits to form the functional branched-chain alpha-keto acid dehydrogenase complex, which is crucial for its enzymatic activity. Post-translational modifications, such as phosphorylation, may occur, influencing the protein's activity and regulation. These structural features are vital for the proper functioning of the BCKDHB protein in metabolic pathways.

## Function
The BCKDHB gene encodes the E1β subunit of the branched-chain α-keto acid dehydrogenase (BCKAD) complex, a crucial mitochondrial multienzyme structure involved in the oxidative catabolism of branched-chain amino acids (BCAAs) such as leucine, isoleucine, and valine. This complex consists of three catalytic components: E1, E2, and E3, with the E1 component, including the E1β subunit, responsible for the decarboxylation of branched-chain α-keto acids (Du2022The; Zneimer1991Regional).

The BCKAD complex plays a vital role in energy production and nitrogen balance within cells by converting BCAAs into acyl-CoA derivatives, which are then utilized in the tricarboxylic acid (TCA) cycle and other metabolic pathways (Du2022The). The activity of the BCKAD complex is regulated by phosphorylation and dephosphorylation, with BCKDH kinase (BCKDK) inhibiting its activity and mitochondrial phosphatase 2C (PP2Cm) activating it (Du2022The).

In healthy human cells, the BCKDHB gene ensures the proper functioning of the BCKAD complex, facilitating the effective breakdown of BCAAs, which is essential for normal metabolic processes. Mutations in this gene can lead to metabolic disorders such as maple syrup urine disease (MSUD) (Zneimer1991Regional).

## Clinical Significance
Mutations in the BCKDHB gene are associated with Maple Syrup Urine Disease (MSUD), a metabolic disorder characterized by the accumulation of branched-chain amino acids (BCAAs) and their corresponding keto acids due to impaired activity of the branched-chain alpha-keto acid dehydrogenase (BCKD) complex (Flaschker2007Description; Wang2012Two). MSUD presents in various forms, with the classic form being the most severe, often manifesting within the first two weeks of life and leading to symptoms such as ketoacidosis, neurological deterioration, and a distinctive maple syrup odor in urine (Quental2008Molecular; Wang2012Two).

The BCKDHB gene encodes the E1 beta subunit of the BCKD complex, and mutations in this gene can lead to reduced enzymatic activity, contributing to the pathogenesis of MSUD. For instance, the R170H and Q346R mutations disrupt the spatial conformation of the E1 component, leading to reduced enzymatic activity and elevated levels of BCAAs and branched-chain keto acids (Wang2012Two). Other mutations, such as p.Pro200Ala and p.Gly278Ser, are associated with milder MSUD variants (Flaschker2007Description). The inheritance pattern of these mutations is autosomal recessive, and they can result in severe clinical manifestations if not diagnosed and managed early (Li2023Identification).

## Interactions
The BCKDHB gene encodes the E1β subunit of the branched-chain α-ketoacid dehydrogenase (BCKD) complex, a crucial component in the catabolism of branched-chain amino acids. The E1 component of the BCKD complex is a heterotetramer composed of two α and two β subunits, which interact extensively with each other to form a stable structure necessary for enzymatic function (Ævarsson2000Crystal; Wang2012Two). The E1β subunit interacts with the E2b binding domain, and these interactions are essential for the assembly and stability of the BCKD complex (Ævarsson2000Crystal).

Mutations in the BCKDHB gene can disrupt these interactions, leading to improper assembly and function of the complex. For instance, the R170H and Q346R mutations affect the spatial interactions between the β-β′ and α-β subunits, destabilizing the E1 component and impairing its catalytic activity (Wang2012Two). Additionally, BCKDHB has been shown to interact with mitochondrial ribosomal proteins such as MRPS9, MRPS11, and MRPS31, suggesting potential roles beyond its known mitochondrial functions (Revathi2021Expression). These interactions highlight the importance of BCKDHB in maintaining the structural integrity and function of the BCKD complex.


## References


[1. (Ævarsson2000Crystal) Arnthor Ævarsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain α-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8(3):277–291, March 2000. URL: http://dx.doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 148 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0969-2126(00)00105-2)

[2. (Wang2012Two) Yue-Ping Wang, Man-Long Qi, Ting-Ting Li, and Yun-Jing Zhao. Two novel mutations in the bckdhb gene (r170h, q346r) cause the classic form of maple syrup urine disease (msud). Gene, 498(1):112–115, April 2012. URL: http://dx.doi.org/10.1016/j.gene.2012.01.082, doi:10.1016/j.gene.2012.01.082. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2012.01.082)

[3. (Li2023Identification) Lulu Li, Xinmei Mao, Nan Yang, Taoyun Ji, Shunan Wang, Yulan Ma, Haihe Yang, Yuting Sang, Jinqi Zhao, Lifei Gong, Yue Tang, and Yuanyuan Kong. Identification of gene mutations in six chinese patients with maple syrup urine disease. Frontiers in Genetics, February 2023. URL: http://dx.doi.org/10.3389/fgene.2023.1132364, doi:10.3389/fgene.2023.1132364. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1132364)

[4. (Revathi2021Expression) Oviya Revathi Paramasivam, Gopal Gopisetty, Jayavelu Subramani, and Rajkumar Thangarajan. Expression and affinity purification of recombinant mammalian mitochondrial ribosomal small subunit (mrps) proteins and protein–protein interaction analysis indicate putative role in tumourigenic cellular processes. The Journal of Biochemistry, 169(6):675–692, January 2021. URL: http://dx.doi.org/10.1093/jb/mvab004, doi:10.1093/jb/mvab004. This article has 7 citations.](https://doi.org/10.1093/jb/mvab004)

[5. (Zneimer1991Regional) Susan M. Zneimer, Kim S. Lau, Roger L. Eddy, Thomas B. Shows, Jacinta L. Chuang, David T. Chuang, and Rody P. Cox. Regional assignment of two genes of the human branched-chain α-keto acid dehydrogenase complex: the e1β gene (bckdhb) to chromosome 6p21–22 and the e2 gene (dbt) to chromosome 1p31. Genomics, 10(3):740–747, July 1991. URL: http://dx.doi.org/10.1016/0888-7543(91)90458-q, doi:10.1016/0888-7543(91)90458-q. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/0888-7543(91)90458-q)

[6. (Flaschker2007Description) N. Flaschker, O. Feyen, S. Fend, E. Simon, P. Schadewaldt, and U. Wendel. Description of the mutations in 15 subjects with variant forms of maple syrup urine disease. Journal of Inherited Metabolic Disease, 30(6):903–909, October 2007. URL: http://dx.doi.org/10.1007/s10545-007-0579-x, doi:10.1007/s10545-007-0579-x. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10545-007-0579-x)

[7. (Du2022The) Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain α-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, July 2022. URL: http://dx.doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnut.2022.932670)

[8. (Quental2008Molecular) Sofia Quental, Sandra Macedo-Ribeiro, Raquel Matos, Laura Vilarinho, Esmeralda Martins, Elisa Leão Teles, Esmeralda Rodrigues, Luísa Diogo, Paula Garcia, Filomena Eusébio, Ana Gaspar, Sílvia Sequeira, Fátima Furtado, Isabel Lança, António Amorim, and Maria João Prata. Molecular and structural analyses of maple syrup urine disease and identification of a founder mutation in a portuguese gypsy community. Molecular Genetics and Metabolism, 94(2):148–156, June 2008. URL: http://dx.doi.org/10.1016/j.ymgme.2008.02.008, doi:10.1016/j.ymgme.2008.02.008. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2008.02.008)